Porphyra umbilicalis (Nori)
Porphyra umbilicalis, commonly known as Nori, is a red alga rich in phycobiliproteins and sulfated polysaccharides. It provides essential nutrients including EPA omega-3 fatty acids and may serve as a B12 source in vegetarian diets.

Origin & History
Porphyra umbilicalis, commonly known as nori, is a red alga from the Bangiales order that grows in intertidal to shallow subtidal coastal waters worldwide and is often cultivated as a marine crop. It is typically harvested and processed by drying whole thalli into thin sheets, though flakes or powders may also be produced mechanically.
Historical & Cultural Context
Porphyra umbilicalis (nori) has been used for centuries in Asian traditional medicine systems, particularly Chinese and Japanese, for its healing and nourishing properties. Historical cultivation as a marine crop emphasizes its role as a nutrient source, particularly valued for its high protein and B12 content in vegetarian contexts.
Health Benefits
• May address B12 deficiencies in vegetarian diets (preclinical evidence only) • Contains EPA omega-3 fatty acids similar to fish oils (compositional analysis, no clinical trials) • High protein content (32-37% dry weight) may support nutritional needs (compositional data only) • Contains minerals like iron (0.18-0.70 mg/g DW) and iodine (2.4-3.1 mg/g DW) (compositional analysis) • Demonstrates antioxidative properties in laboratory studies (preclinical evidence, reduced by processing)
How It Works
Porphyra umbilicalis provides bioavailable forms of cobalamin, acting as a cofactor for enzymes like methionine synthase crucial for DNA synthesis and nerve function. Its eicosapentaenoic acid (EPA) content integrates into cell membranes, modulating eicosanoid production to support anti-inflammatory responses. Additionally, sulfated polysaccharides like porphyran may exhibit immunomodulatory effects by interacting with immune cell receptors.
Scientific Research
No human clinical trials, RCTs, or meta-analyses specifically on Porphyra umbilicalis or nori were identified in the available research. All evidence comes from preclinical studies suggesting immunomodulation, anticancer, antihyperlipidemic, and antioxidative effects, but these lack human validation.
Clinical Summary
Current evidence for Porphyra umbilicalis is largely based on compositional analysis and preclinical studies. For instance, some in vitro and animal studies suggest certain Nori varieties contain B12 analogs that may address deficiencies in vegetarian diets, though human bioavailability requires further investigation. While compositional analysis confirms a high protein content (32-37% dry weight) and EPA omega-3 fatty acids, clinical trials specifically demonstrating health benefits from Nori consumption are lacking. Human studies are needed to substantiate efficacy for specific health outcomes.
Nutritional Profile
Porphyra umbilicalis (Nori) is a nutritionally dense red alga with a high protein content of 32-37% dry weight (DW), comprising a complete amino acid profile including essential amino acids such as leucine, lysine, and phenylalanine. Carbohydrates account for approximately 40-60% DW, primarily as porphyran (a sulfated galactan unique to Porphyra spp.) and floridean starch, contributing to dietary fiber content of ~35% DW. Lipid content is low at 1-5% DW, yet nutritionally significant due to the presence of EPA (eicosapentaenoic acid, 20:5n-3) comprising approximately 25-50% of total fatty acids, with minimal DHA. Vitamin B12 (cobalamin) is present at approximately 55-60 µg/100g DW, though bioavailability is debated as a portion may exist as pseudovitamin B12 (adeninylcobamide), which is largely inactive in humans; genuine corrinoid B12 analogues have been confirmed in some analyses. Vitamin C content is approximately 15-50 mg/100g fresh weight. Provitamin A (beta-carotene) is present at ~0.3-1.5 mg/100g DW. Key minerals include iodine at 2.4-3.1 mg/g DW (notably high; bioavailability estimated at ~50-75%), iron at 0.18-0.70 mg/g DW (non-heme form; bioavailability enhanced by co-occurring vitamin C but reduced by porphyran fiber), calcium at ~70-100 mg/100g DW, magnesium at ~200 mg/100g DW, and potassium at ~400 mg/100g DW. Bioactive compounds include phycoerythrin and phycocyanin (phycobiliproteins), mycosporine-like amino acids (MAAs) acting as UV-absorbing antioxidants, and r-phycoerythrin. Taurine is present at ~500 mg/100g DW. Bioavailability of protein is estimated at 70-75% (lower than animal protein due to cell wall polysaccharide encapsulation), and fat-soluble nutrient absorption benefits from concurrent dietary fat intake.
Preparation & Dosage
No clinically studied dosage ranges are available as human trials are absent. Typical consumption is as dried sheets or flakes in food with variable nutrient levels (protein 32-37%, taurine up to 979 mg/100g DW), but no standardized doses have been tested clinically. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin C, Iron supplements, B-complex vitamins, Omega-3 supplements, Selenium
Safety & Interactions
Porphyra umbilicalis is generally considered safe when consumed as food. However, due to its iodine content, excessive consumption might pose a risk for individuals with thyroid disorders, potentially exacerbating hyper- or hypothyroidism. As with other sea vegetables, there is a potential for accumulation of heavy metals, although Nori typically has lower levels than some other seaweeds; sourcing from reputable suppliers is advisable. Pregnant or breastfeeding individuals should consult a healthcare provider due to potential high iodine intake, and those on anticoagulants should exercise caution due to possible anticoagulant properties from sulfated polysaccharides.